Vaxxinity (VAXX)
Vaxxinity, Inc., a biotechnology company, focuses on developing product candidates for human use in the fields of neurology, cardiovascular diseases, and corona...
- Open
- 0.0002
- High
- 0.0002
- Low
- 0.0001
- Prev. Close
- 0.0001
- Volume
- 227
- Turnover
- 3.22
- Avg Price
- 0.0142
- Bid/Ask Ratio
- --
- Amplitude
- 100.00%
- 52wk High
- 0.2000
- Volume Ratio
- 0.29
- Turnover Ratio
- 0.00%
Vaxxinity Analyst Rating
View moreForecast & Rating
Mar 22, 2024Price forecast
$7.003499900.00%
Forecast & RatingStrong buy
1analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- Weekly Review · 2 days ago, 01:53 AM
Weekly Recap | Abbvie +6.21%, closing in on record highs
- Weekly Review · 2 days ago, 01:16 AM
Weekly Recap | Ark Innovation ETF +6.3%, crypto and biotech lead the charge
- Weekly Review · 2 days ago, 12:44 AM
Weekly Recap | Sutro Biopharma +2.73%, consensus target well above spot
- Weekly Review · 2 days ago, 12:44 AM
Weekly Recap | United Therap +2.68%, most brokers rate it buy
- Weekly Review · 2 days ago, 12:07 AM
Weekly Recap | ImmunityBio this week, a quiet, low-volume week
- Weekly Review · 2 days ago, 11:51 PM
Weekly Recap | CRISPR Therap +11.11%, consensus target above spot
